Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials.
Jennifer L LundJenna CacciatoreRachael G TylockI-Hsuan SuSaloni SharmaSharon Peacock HintonSabirah SmithMolly A NowelsXiaomeng Chen MsphPaul R DubersteinLaura C HansonSupriya G MohilePublished in: JCO clinical cancer informatics (2024)
Extending clinical trial mortality follow-up through linkage with external data sources was feasible and accurate. Future cancer clinical trials should collect necessary consent and patient identifiers for vital status linkages that can enhance understanding of longer-term outcomes.
Keyphrases
- clinical trial
- advanced cancer
- palliative care
- cardiovascular events
- papillary thyroid
- phase ii
- case report
- risk factors
- physical activity
- open label
- electronic health record
- double blind
- high resolution
- study protocol
- drinking water
- randomized controlled trial
- genome wide
- big data
- phase iii
- squamous cell
- community dwelling
- squamous cell carcinoma
- mass spectrometry
- lymph node metastasis
- coronary artery disease
- metabolic syndrome
- human immunodeficiency virus
- hiv infected
- artificial intelligence
- machine learning
- gestational age
- weight loss